entertainment -WSS

entertainment

author：leisure time 2025-09-03 14:35:21 - browse：542

Adobe

You didn’t need machine learning to make one prediction about the year’s biggest conference for health care investors, which was held in San Francisco last week. It was going to rain.

Recursion, a biotechnology firm that uses machine learning for drug development and that was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment. As the heavens opened, Recursion employees handed out black umbrellas emblazoned with the Recursion logo and lined with neon images of cells. It was one of a series of publicity grabs from the company, including a satellite event featuring Nvidia’s famous CEO, Jensen Huang, who has become a Wall Street rock star as his company’s stock has exploded due to rising expectations for AI, reaching a $1 trillion market value, the sixth highest in the world.

Seeing the square outside the Westin St. Francis, where the J.P. Morgan Healthcare Conference has been held for 42 years, fill with Recursion’s umbrellas was a little like seeing the message that AI was ready for its debut come to life. But it was also true that not everyone was ready to embrace that message.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： J&J lung cancer data amount to new salvo against AstraZeneca

hotspot

WSS

Lung cancer is America's deadliest cancer. Yet so few get screened

STAT Readout: Friday, Oct. 20 biotech updates

Results on Novartis prostate cancer therapy could expand its use

ADCs take center stage as promising cancer treatments

The problems with dementia villages

Merck, Daiichi strike cancer drug pact worth up to $22 billion

knowledge

entertainment

leisure time

Sports medicine is finally prioritizing gender equality

Baltimore teen accused of firing into crowd during block party mass shooting

Cancer drug shortages should be causing more outrage

The pain doctors face in trying to build their families

Continuity nursing helped my family in our darkest PICU moments

STAT Readout Newsletter: Biotech news today

Bright Health sells Medicare Advantage business to Molina

Merck, Daiichi strike cancer drug pact worth up to $22 billion

The high cost of giving birth even with insurance

Cassava Sciences’ Alzheimer’s clinical trials should be halted

leisure time

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

The pain doctors face in trying to build their families

Trump's false claims about Georgia's 2020 election long debunked

Ukraine taking heavy casualties 10 weeks into its counteroffensive

ProMED sees offers of support, but its future remains unclear

Why a market frenzy over new weight loss drugs defies logic

hotspot

hotspot

focus

hotspot